1. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. (1st August 2021) Authors: Abels, C.; Soeberdt, M.; Kilic, A.; Reich, H.; Knie, U.; Jourdan, C.; Schramm, K.; Heimstaedt‐Muskett, S.; Masur, C.; Szeimies, R.‐M. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. (2nd March 2021) Authors: Abels, C.; Soeberdt, M.; Kilic, A.; Reich, H.; Knie, U.; Jourdan, C.; Schramm, K.; Heimstaedt‐Muskett, S.; Masur, C.; Szeimies, R.‐M. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First Episode Psychosis and intensity of care after discharge : difference at two years between lost and maintained follow-up patients. (1st June 2022) Authors: Bordas, R.; Laffont, E.; Jourdan, C.; Pujol, M.; Lamary, L. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial*. (1st March 2021) Authors: Gabes, M.; Jourdan, C.; Schramm, K.; Masur, C.; Abels, C.; Kamudoni, P.; Salek, S.; Apfelbacher, C. Journal: British journal of dermatology Issue: Volume 184:Number 3(2021) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial. (1st March 2021) Authors: Gabes, M.; Jourdan, C.; Schramm, K.; Masur, C.; Abels, C.; Kamudoni, P.; Salek, S.; Apfelbacher, C. Journal: British journal of dermatology Issue: Volume 184:Number 3(2021) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial. (1st September 2020) Authors: Gabes, M.; Jourdan, C.; Schramm, K.; Masur, C.; Abels, C.; Kamudoni, P.; Salek, S.; Apfelbacher, C. Journal: British journal of dermatology Issue: Volume 184:Number 3(2021) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Implication of substance use in suicidal or violent behaviours in a first episode psychosis spectrum disorder population : A 45 patients retrospective study. (13th April 2021) Authors: Bordas, R.; Jourdan, C.; Basso, C.; Laffont, E.; Pujol, M.; Lamary, L. Journal: European psychiatry Issue: Volume 64:Supplement 1(2021) Page Start: S512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Predictive factors for 1-year outcome of a cohort of patients with severe traumatic brain injury (TBI): Results from the PariS-TBI study. (August 2013) Authors: Jourdan, C.; Bosserelle, V.; Azerad, S.; Ghout, I.; Bayen, E.; Aegerter, P.; Weiss, J. J.; Mateo, J.; Lescot, T.; Vigué, B.; Tazarourte, K.; Pradat-Diehl, P.; Azouvi, P. Journal: Brain injury Issue: Volume 27:Number 9(2013) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗